February 14, 2020
January 29, 2021
This email covers industry news and events such as details on the upcoming Entrepreneur & Investor Summit, ProLung’s non-invasive, predictive analytic for lung cancer screening (ProLung Test™) being designated a ‘Breakthrough Device’ by the FDA, the life sciences industry’s Day on the Hill, and the Asia Pacific Device Summit.
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize